3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
44
Breast Neoplasms
33
Neoplasms
29
Neoplasm Metastasis
23
Melanoma
23
Leukemia, Myeloid, Acute
20
Prostatic Neoplasms
19
Colorectal Neoplasms
18
Multiple Myeloma
17
Lung Neoplasms
16
Lymphoma, Non-Hodgkin
14
Recurrence
13
Myelodysplastic Syndromes
13
Squamous Cell Carcinoma of Head and Neck
12
Ovarian Neoplasms
12
Lymphoma, Large B-Cell, Diffuse
11
Carcinoma, Renal Cell
11
Urinary Bladder Neoplasms
10
Pancreatic Neoplasms
10
Glioblastoma
10
Carcinoma, Hepatocellular
10
Uterine Cervical Neoplasms
9
Brain Neoplasms
9
Head and Neck Neoplasms
8
Triple Negative Breast Neoplasms
7
Stomach Neoplasms
7
Rectal Neoplasms
7
Lymphoma, Follicular
7
Lymphoma
7
Hodgkin Disease
7
Interventions
Vinblastine
1
Nivolumab
1
Cyclophosphamide
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Childhood Solid Tumor
×
90 days
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled